Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Arbutus Biopharma Corp (NASDAQ:ABUS)

6.55
Delayed Data
As of Sep 22
 -0.45 / -6.43%
Today’s Change
2.35
Today|||52-Week Range
7.85
+167.35%
Year-to-Date

Today’s Trading

Previous close7.00
Today’s open7.00
Day’s range6.35 - 7.00
Volume827,063
Average volume (3 months)201,105
Market cap$360.4M
Dividend yield--
Data as of 3:59pm ET, 09/22/2017

Growth & Valuation

Earnings growth (last year)-440.30%
Earnings growth (this year)+80.00%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-94.01%
P/E ratio--
Price/Sales87.21
Price/Book1.77

Competitors

 Today’s
change
Today’s
% change
OVIDOvid Therapeutics In...-0.20-2.31%
CPRXCatalyst Pharmaceuti...0.000.00%
DRRXDURECT Corp+0.04+2.37%
STMLStemline Therapeutic...0.000.00%
Data as of 3:59pm ET, 09/22/2017

Financials

Next reporting dateNovember 3, 2017
EPS forecast (this quarter)-$0.37
Annual revenue (last year)$1.5M
Annual profit (last year)-$384.2M
Net profit margin-25,765.53%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark J. Murray
Chief Financial Officer &
Executive Vice President
Bruce G. Cousins
Corporate headquarters
Burnaby, British Columbia

Forecasts